« Controversy over the Causes of Alzheimer's | Main | Just Say No to Intergenerational Living? »

June 28, 2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d83451d58669e20133f1e87ed7970b

Listed below are links to weblogs that reference What's the Best Alzheimer's Care? Disappointing Results from a French Study:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

Richard Taylor

If there was a Nobel Prize for excellence in explaining things related to dementia research and/or a a Pulitzer Prize for on-line journalism benefiting people with dementia and their professional dementia/caregiver communities - surely you should/would win it year after year after year. Everyone with dementia, everyone who is a professional who "treats people living with the symptoms of dementia, and every family caregiver should read your blog on a regular and timely basis. You are passionate and objective. You are reasonable, evidence based, and your conclusions are always generous, open ended, and kind to all, yet always true to the facts! Thank you for being you.
Richard

Danny George

well said Richard. Mona, great article, and so glad to see Martial and Anne-Claude featured in The Tangled Neuron - they are truly committed to humanizing care for persons with dementia.

Mhdonohue

This result comes as no surprise. The overall reason in my view is this:

Attempting to prescribe uniformly for Alzheimer’s Disease (AD) when the last thing it is can be called uniform in its manifestation in the persons having it. There are as many kinds of AD as there are people who have it. Each person having it is in a different stage of it from day to day, different from all others bearing a similar diagnosis.

Uniformity is the giant fault of our modern data dependent culture that needs to classify before it can concern itself with anything. I call this sin “Homogenization!” Like the inverse of Murphy’s law we homogenize all or our programs into their lowest denominator of ineffectiveness.

Treatment of AD, particularly in the Early Stage of it, when a person can be kept there longer by it, needs to be measured by the positive response of the person getting it. Does the patient respond, does it help, does it improve. What works is what should by utilized.

Reducing treatment to a data friendly consistent formula decreases its possibility of being effective.

Perhaps in the classification process while decentralizing treatment modality we ought to centralize diagnostic criteria broadening the class of finding of symptoms so more fits into the ambit of AD, forcing treatment to recognize difference by reason of its generality.

The comments to this entry are closed.

Enter your email address:

Delivered by FeedBurner